Today at AMUG 2019, after 3.5 years of development, Dyndrite Corporation emerged from stealth, launching the Dyndrite Accelerated Geometry Kernel (AGK) — the world's first fully GPU-native...

Today at AMUG 2019, Dyndrite Corporation announced the launch of its Developer Program and inaugural members of its Developer Council - a select group of industry leaders committed to advancing...

At the American Association for Cancer Research (AACR) Annual Meeting 2019 (March 29 to April 3 in Atlanta, GA) ATCC, a global leader in biological materials/information development, will present...

Cyteir Therapeutics, a leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases,...

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer....